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 Leigh Disease with Brainstem Involvement in Complex I 
Defi ciency due to Assembly Factor NDUFAF2 Defect 
genicity only for a small part of the entire com-
plex I defi ciency patients. For more than 50  % of 
the patients molecular diagnostics fail to detect 
the cause of the disease. In previous reports 
assembly factor mutations have been shown to 
cause complex I defi ciency. 
 Ogilvie and colleagues showed fi rst that the NDU-
FAF2 gene, which shares similarities in amino 
acid sequence with subunit NDUFA12, serves as 
complex I assembly factor  [12] , as well as NDU-
FAF1, C6ORF66, C8ORF38, C20ORF7 and NDU-
FAF3, for which mutations have been described 
 [1,  6,  7,  12 – 15,  17] . Herein, we describe a patient 
with complex I defi ciency in both muscle and 
fi broblasts harbouring a new mutation in the 
NDUFAF2 gene. We compare the clinical picture 
with previously published cases and summarize 
the unique neuropathological pattern of the 
known patients with NDUFAF2 mutations. 
 Case Report 
 ▼ 
 The patient was the fi rst child of non-consan-
guineous Austrian parents and was born after an 
uneventful pregnancy. Early psychomotor devel-
opment was moderately delayed. He was able to 
 Introduction 
 ▼ 
 With a minimum birth prevalence of at least 
1:5  000  [16] disorders of the mitochondrial respi-
ratory chain account for a main part of inherited 
metabolic diseases. Embedded within the inner 
mitochondrial membrane, the respiratory chain 
is made up of 5 enzyme complexes which pro-
duce ATP by oxidative phosphorylation. Espe-
cially high energy-dependent organs like brain, 
heart and skeletal muscle are vulnerable to 
defects of the aerobic energy metabolism. 
 Isolated complex I defi ciency encompasses about 
one third of these hereditary defects in the mito-
chondrial energy generating system  [2,  9] . Being 
the largest complex of the respiratory chain, 
complex I contains 45 subunits, which are under 
genetic control of both mitochondrial and nuclear 
genes  [4] . Pathogenic mutations causing complex 
I defects have been described in all 7 mitochon-
drial encoded subunits and 12 nuclear genes, 
namely NDUFS1, NDUFS2, NDUFS3, NDUFS4, 
NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV2, 
NDUFA1, NDUFA2 and NDUFA11, which are 
highly conserved and account for a large number 
of diﬀ erent phenotypes in the aﬀ ected patients 
 [2,  3,  5] . However, these mutations explain patho-
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 Abstract 
 ▼ 
 Mitochondrial NADH: ubiquinone oxidoreduct-
ase (complex I) defi ciency accounts for most 
defects in mitochondrial oxidative phosphoryla-
tion. Pathogenic mutations have been described 
in all 7 mitochondrial and 12 of the 38 nuclear 
encoded subunits as well as in assembly factors 
by interfering with the building of the mature 
enzyme complex within the inner mitochondrial 
membrane. We now describe a male patient 
with a novel homozygous stop mutation in the 
 NDUFAF2 gene. The boy presented with severe 
apnoea and nystagmus. MRI showed brainstem 
lesions without involvement of basal ganglia and 
thalamus, plasma lactate was normal or close to 
normal. He died after a fulminate course within 
2 months after the fi rst crisis. Neuropathology 
verifi ed Leigh disease. We give a synopsis with 
other reported patients. Within the clinical spec-
trum of Leigh disease, patients with mutations in 
 NDUFAF2 present with a distinct clinical pattern 
with predominantly brainstem involvement on 
MRI. The diagnosis should not be missed in spite 
of the normal lactate and lack of thalamus and 
basal ganglia changes on brain MRI. 
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walk at the age of 22 months. Horizontal nystagmus was noticed 
at the age of 14 months and improved with orthoptist therapy. 
At the age of 26 months, during pneumonia, he was found to be 
apnoeic and needed respiratory assistance. The CT scan of the 
brain was normal, cerebrospinal fl uid (CSF) showed no signs of 
central nervous system infection. He recovered promptly and 
was discharged from hospital after 8 days. Metabolic screening, 
virological investigations and lactate measurements in plasma 
and CSF were normal. 
 3 weeks later, with respiratory infection, he was found to be 
apnoeic, cyanotic and comatose. On admission he was mechani-
cally ventilated and presented with foot drop position and bilat-
eral positive Babinski signs. Neuroimaging at the age of 27 month 
(  ● ▶  Fig. 1 ) revealed on T 2 -weighted images lesions in the upper 
cervical spinal cord, the medulla oblongata, in the pontine teg-
mentum, in the midbrain in the substantia nigra and the periaq-
ueductal region (  ● ▶  Fig.  1a ). In the cerebral white matter patchy 
and not completely confl uent lesions, mainly located in the fron-
tal and parietal deep white matter, are seen. The corpus callo-
sum, internal capsule and basal ganglia and thalami are spared 
(  ● ▶  Fig.  1b ). 
 On admission lactate was elevated (serum 4.2  mmol / L, reference 
value   <  2.2  mmol / L; CSF 6  mmol / L, reference value   <  2.1  mmol / L), 
subsequently lactate levels were within the normal range. CSF 
protein was normal. Fundoscopy showed pale optic discs. Audi-
tory evoked potentials disclosed signs of lesions in the rostral 
pontine auditory pathway. 3 weeks later the patient died under 
mechanical ventilation of cardiac arrest at the age of 27 months. 
 Histological fi ndings 
 Autopsy and biopsies of skin, muscle and liver were performed. 
Neuropathological examination of CNS revealed softening and 
brown discolouration of the substantia nigra and the tegmen-
tum of the brainstem (  ● ▶  Fig.  1c ) and typical signs of Leigh dis-
ease with necrosis, spongy state and capillary proliferation 
(  ● ▶  Fig.  1d ) predominantly in the brainstem (substantia nigra, 
tegmentum of mesencephalon, pons and medulla oblongata), 
the optic nerves and chiasma. Some less pronounced changes 
were found in nucleus dentatus cerebelli and the uppermost spi-
nal cord, and mild involvement of the medial thalamus and 
hypothalamus. The mammillary bodies were not aﬀ ected. Dor-
sal spinal tracts, spinocerebral tracts and dorsal spinal nerve 
roots displayed Wallerian degeneration. There were no signs of 
hypoxic damage. 
 Measurement of respiratory chain enzyme activities in 
fi broblasts and muscle 
 Activities of the respiratory chain complexes were determined 
in isolated fi broblast mitochondria and in muscle homogenate 
by standard spectrophotometric methods  [10] . The complex I 
activity was clearly reduced with 12  % residual activity of 
the lowest control value in muscle and 59  % in fi broblasts. In 
muscle and fi broblast complexes II and III were also reduced 
(presumably secondary eﬀ ects of the complex I defi ciency) 
(see   ● ▶  Table 1 ). 
 Mutation analysis 
 Genomic DNA was extracted from skeletal muscle homogenate 
by proteinase K treatment followed by phenol / chloroform 
extraction. Mutation screen in candidate genes including NDU-
FAF2 was performed by high-resolution melting analysis using 
Idaho LightScanner Technology as described by Meisinger et  al. 
in 2009  [11] . All exons of NDUFAF2 were PCR amplifi ed by 
intronic primers (available on request) and altered melting 
curves compared were directly sequenced with BigDye Cycle 
sequencing kit (Applied Biosystems). Sanger sequencing of the 
entire mitochondrial DNA failed to detect a mutation. High-res-
olution melting profi le analysis of exonic sequences from NDU-
FAF2 revealed a novel homozygous nonsense mutation c.9G  >  A 
introducing an early stop codon at position 3 of NDUFAF2 (p.
Trp3X,   ● ▶  Fig. 2 ). 
 Discussion 
 ▼ 
 Patients with complex I defi ciencies present with a heterogene-
ous spectrum of clinical phenotypes, refl ecting the complex 
structure and its function within the respiratory chain. So far, in 
more than 50  % of the patients molecular diagnosis failed to 
detect the cause of disease. There are very few patients pub-
lished with complex I defi ciency due to mutations in assembly 
factors and only 4 patients published with a defect of  NDUFAF2 . 
We present a new case with a novel mutation in this assembly 
factor and point out the common clinical and neuropathological 
patterns of all so far known patients. 
 Ogilvie et  al. (2005,   ● ▶  Table 2 )  [12] reported on a girl with a 
severe childhood-onset progressive encephalopathy caused by 
mutation the NDUFAF2 gene. The clinical course was character-
ized initially by nystagmus and a wide-based gait at the age of 14 
months. At the age of 3 years, a crisis during an infection was 
marked by acute ataxia, lethargy, decreased refl exes and signs of 
 Fig. 1  MRI of brain (T 2 -weighted images) shows increased signal in the midbrain in the substantia nigra ( a : gross arrow) and the periaqueductal region 
( a : fi ne arrow), corpus callosum, internal capsule and basal nuclei are spared ( b ). Autopsy shows softening and brown discolouration of substantia nigra and 
subaqueductal area of the midbrain ( c ), histopathology: spongy state, necrosis and capillary proliferation of pontine tegmentum (cresyl violet   ×  100) ( d ). 
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optic atrophy. At the age of 8 years she worsened with dysphagia, 
sleep apnoea and respiratory failure. She remained comatose 
and died at the age of 13 years. Neuropathology proved Leigh 
disease. Cerebral cMRI exhibited symmetric lesions in the 
mamillothalamic tracts, substantia nigra, medial lemniscus, 
medial longitudinal fasciculus and spinothalamic tracts. Basal 
ganglia and thalamus were not aﬀ ected. Blood lactate, liver func-
tion and echocardiogram were normal almost all the time, so 
the authors stated that clinical presentation, laboratory and 
cMRI fi ndings did not resemble typical Leigh syndrome. 
 Barghuti et  al. (2008) added 2 more patients who were identi-
fi ed by homozygosity mapping  [1] . The clinical course 
(see   ● ▶  Table 2 ) was marked by apnoea, nystagmus, optic nerve 
atrophy (observed in 1 patient) and early death 4 and 13 months 
after the fi rst crisis, respectively. Both patients had normal blood 
lactate levels and very similar cMRI changes of the brainstem as 
the patient from Ogilvie et  al. Therefore, Barghuti et  al. postu-
lated that patients with NDUFAF2 mutations display a unique 
pattern of degenerative changes in neuroradiology. 
 Our case resembles the fi ndings in the above-mentioned 
patients. There was a moderate delay in psychomotor develop-
ment and nystagmus prior to the fi rst crisis with severe apnoea 
during an infection. The second crisis within 3 weeks led to 
death due to cardiorespiratory arrest. The patient had normal or 
close to normal blood lactate levels (in CSF lactate was consider-
able increased) and cMRI fi ndings were very similar to those of 
the so far described patients. The diagnosis of Leigh disease was 
proven by neuropathology (  ● ▶  Fig.  1c, d ). It can be speculated 
that other clinically similar patients with NDUFAF2 mutations 
might have been missed for diagnosis on intensive care ward 
units. The severe clinical picture with acute fulminant and lethal 
respiratory failure without lactate elevation and the atypical 
neuroradiological presentation might have misled to other diag-
nostic considerations than mitochondrial encephalopathy. 
 Very recently, Hoefs et  al. (2009) published a girl with an NDU-
FAF2 mutation  [7] , who presented with nystagmus at the age of 
3 months, followed by feeding diﬃ  culties, renal tubular acidosis, 
muscular hypotonia and dyskinetic movements. She died at age 
of 1 year due to respiratory failure (  ● ▶  Table 2 ). Plasma lactate 
levels were moderately elevated and cMRI revealed high signal 
abnormalities in thalamus, brainstem and spinal cord. This case 
shows that neuroradiology fi ndings in patients with NDUFAF2 
mutations are not always as unique as postulated by Barghuti 
et  al.  [1] . 
 All NDUFAF2 patients harboured loss of function mutations with 
a truncated protein useless in complex I assembly  [7,  8,  12] . 
 Median complex I residual activity was 31  % of the lowest con-
trol value with a range of 12  −  55  % in the 5 patients suggesting 
that mutated NDUFAF2 has a great infl uence on proper complex 
I function, although the residual activity does not correlate to 
the patient ’ s clinical course. Nevertheless, there are specifi c fea-
tures which have been observed in patients with NDUFAF2 
mutations. 
 Patients expired at a median age of 2 years (range from 1 up to 
13 years). Clinical hallmarks are nystagmus, optic nerve atrophy, 
apnoea and respiratory failure as signs of the mainly aﬀ ected 
 Table 1  Respiratory chain enzyme activities in fi broblasts and muscle. 
 Muscle  Patient *  Normal Range *  Patient * *  Normal Range * * 
 complex I (CI)  2  30 – 65  0.02  0.17 – 0.26 
 complex I  +  III (C13)  7  27 – 58  0.05  0.13 – 0.19 
 complex II (CII)  39  53 – 100  0.29  0.30 – 0.36 
 complex II  +  III (C23)  12  41 – 75  0.09  0.20 – 0.28 
 complex III (CIII)  81  230 – 490  0.61  1.30 – 1.96 
 complex V (CV)  108  78 – 180  0.81  0.42 – 0.70 
 cytochrome c oxidase (COX)  113  205 – 739  0.85  1.24 – 2.38 
 citrate synthase (CS)  133  160 – 310   
 Fibroblasts  Patient *  Normal Range *  Patient * *  Normal Range * * 
 complex I (CI)  6  15 – 53  0.02  0.05 – 0.09 
 complex I  +  III (C13)  16  102 – 343  0.05  0.24 – 0.58 
 complex II (CII)  99  103 – 285  0.34  0.37 – 0.48 
 complex II  +  III (C23)  161  167 – 314  0.55  0.39 – 0.72 
 complex III (CIII)  298  283 – 1174  0.98  1.17 – 1.99 
 complex V (CV)  45  36  −  167  0.15  0.15 – 0.39 
 cytochrome c oxidase (COX)  381  392 – 939  1.35  1.30 – 1.68 
 citrate synthase (CS)  297  242 – 590   
 *  Units / g protein 
 * *  Units / unit citrate synthase 
G
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 Fig. 2  DNA sequence analysis of the patient revealed a homozygous 
missense mutation (c.9G  >  A) resulting in a premature stop codon instead 
of a tryptophan at position 3 (p.Trp3X).  a : control;  b : patient. D
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brainstem. The clinical course in all patients was marked by an 
early onset and progressive course. Furthermore, 4 of the 5 
patients presented with acute episodes of encephalopathy dur-
ing infections and were stable in the interval. On cMRI, brain-
stem lesions without changes in thalami and basal ganglia on 
T 2 -weighted images are found in 4 out of 5 patients. Plasma lac-
tate was normal in 3 of 5 patients and in the remaining only 
slightly elevated. CSF lactate levels were normal in 2 and ele-
vated in 2 patients. 
 In conclusion, the diagnosis of a complex I assembly defect due 
to an NDUFAF2 mutation should not be missed. The lack of cMRI 
changes in thalamus and basal ganglia and normal or close to 
normal plasma and CSF lactate levels might mislead to other 
than mitochondrial diseases. 
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